Compounds > sulfaphenazole
Page last updated: 2024-08-16

sulfaphenazole and ticrynafen

sulfaphenazole has been researched along with ticrynafen in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyama, R; Jones, JP; Rao, S; Rettie, A; Schrag, M; Trager, WF1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Attias, R; Dansette, PM; Mansuy, D; Poli-Scaife, S1
Assrir, N; Dansette, PM; Jaouen, M; Jean, P; Mansuy, D; Marques-Soares, C; Melet, A; Pilar Lopez-Garcia, M; Sari, MA1

Other Studies

5 other study(ies) available for sulfaphenazole and ticrynafen

ArticleYear
A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.
    Journal of medicinal chemistry, 2000, Jul-27, Volume: 43, Issue:15

    Topics: Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Ligands; Models, Biological; Models, Molecular; Protein Binding; Reproducibility of Results; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Structure-Activity Relationship; Sulfaphenazole; Sulfonamides; Warfarin

2000
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
The substrate binding site of human liver cytochrome P450 2C9: an NMR study.
    Biochemistry, 1997, Oct-21, Volume: 36, Issue:42

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P-450 Enzyme System; Diclofenac; Humans; Isomerism; Kinetics; Lauric Acids; Microsomes, Liver; Models, Chemical; Models, Molecular; NADPH-Ferrihemoprotein Reductase; Nuclear Magnetic Resonance, Biomolecular; Protein Conformation; Rats; Spectrophotometry; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sulfaphenazole; Ticrynafen

1997
Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.
    Archives of biochemistry and biophysics, 2003, Jan-01, Volume: 409, Issue:1

    Topics: Amino Acids; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Crystallography, X-Ray; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; Humans; Kinetics; Microsomes; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Phenylalanine; Protein Binding; Protein Structure, Tertiary; Software; Spectrophotometry; Substrate Specificity; Sulfaphenazole; Ticrynafen; Time Factors; Ultraviolet Rays; Yeasts

2003